Skip to main content
SpringerLink
Log in

Topical Corticosteroid During Pregnancy: Indications, Safety and Precautions

  • Chapter
  • First Online:
A Treatise on Topical Corticosteroids in Dermatology

  • 1159 Accesses

Abstract

The systemic availability of topical corticosteroids alters during pregnancy due to alterations in the cutaneous hydration and blood flow. Topical corticosteroids are commonly used to treat cutaneous manifestation associated with inflammatory conditions, autoimmune response as well as dermatoses associated with atopy such as atopic dermatitis, contact dermatitis, psoriasis and lichen planus. During the first trimester of pregnancy as per existing data the safety of corticosteroids is difficult to interpret and often conflicting. Due to concerns for possible fetal harm, the pregnant women sometimes get under treated because of ‘steroid phobia’.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sulzberger MB, Witten VH. The effect of topically applied compound F in selected dermatoses. J Invest Dermatol. 1952;19(2):101–2.

    Article  CAS  PubMed  Google Scholar 

  2. Chi CC, Wang SH, Kirtschig G, Wojnarowska F. Systematic review of the safety of topical corticosteroids in pregnancy. J Am Acad Dermatol. 2010;62(4):694–705. Epub 2010 Feb 1

    Article  PubMed  Google Scholar 

  3. Narama I. Reproduction studies of diflorasone diacetate (DDA). IV. Teratogenicity study in rabbits by percutaneous administration. Pharmacometrics. 1984;28(2):241–50.

    CAS  Google Scholar 

  4. Robertson DB, Maibach HI. Topical corticosteroids. Int J Dermatol. 1982;21:59–67.

    Article  CAS  PubMed  Google Scholar 

  5. Turpeinen M. Adrenocortical response to adrenocorticotropic hormone in relation to duration of topical therapy and percutaneous absorption of hydrocortisone in children with dermatitis. Eur J Pediatr. 1989;148:729–31.

    Article  CAS  PubMed  Google Scholar 

  6. Sifton DW, editor. Physicians’ desk reference. 56th ed. Montvale: Medical Economics Company; 2002.

    Google Scholar 

  7. Tschen EH, Bucko AD. Assessment of HPA-axis suppression with fluticasone cream 0.05% in patients with extensive psoriasis or eczema. Clin Drug Investig. 1998;16:111–6.

    Article  CAS  PubMed  Google Scholar 

  8. Kecskes A, Heger-Mahn D, Kuhlmann RK, et al. Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activity. J Am Acad Dermatol. 1993;29:576–80.

    Article  CAS  PubMed  Google Scholar 

  9. Mattison DR. Transdermal drug absorption during pregnancy. Clin Obstet Gynecol. 1990;33:718–27.

    Article  CAS  PubMed  Google Scholar 

  10. Sun K, Yang K, Challis JR. Glucocorticoid actions and metabolism in pregnancy: implications for placental function and fetal cardiovascular activity. Placenta. 1998;19:353–60.

    Article  CAS  PubMed  Google Scholar 

  11. Murphy BE, Clark SJ, Donald IR, et al. Conversion of maternal cortisol to cortisone during placental transfer to the human fetus. Am J Obstet Gynecol. 1974;118:538–41.

    Article  CAS  PubMed  Google Scholar 

  12. Gitau R, Cameron A, Fisk NM, et al. Fetal exposure to maternal cortisol. Lancet. 1998;352:707–8.

    Article  CAS  PubMed  Google Scholar 

  13. Gitau R, Fisk NM, Teixeira JM, et al. Fetal hypothalamic–pituitary–adrenal stress responses to invasive procedures are independent of maternal responses. J Clin Endocrinol Metab. 2001;86:104–9.

    CAS  PubMed  Google Scholar 

  14. Beitins IZ, Bayard F, Ances IG, et al. The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr. 1972;81:936–45.

    Article  CAS  PubMed  Google Scholar 

  15. Miller NM, Williamson C, Fisk NM, et al. Infant cortisol response after prolonged antenatal prednisolone treatment. BJOG. 2004;111:1471–4.

    Article  CAS  PubMed  Google Scholar 

  16. Murphy VE, Fittock RJ, Zarzycki PK, et al. Metabolism of synthetic steroids by the human placenta. Placenta. 2007;28:39–46.

    Article  CAS  PubMed  Google Scholar 

  17. Yamada H, Nakano M, Ichihashi T. Fetal concentration after topical application of betamethasone 17,21-dipropionate (S-3440) ointment and teratogenesis in mice and rabbits. Pharmacometrics. 1981;21(4):645–55.

    CAS  Google Scholar 

  18. Sifton DW. Physicians’ desk reference. 6th ed. Medical Economics Company: Montvale; 2002.

    Google Scholar 

  19. Seckl JR, Cleasby M, Nyirenda MJ. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming. Kidney Int. 2000;57:1412–7.

    Article  CAS  PubMed  Google Scholar 

  20. Warrell DW, Taylor R. Outcome for the foetus of mothers receiving prednisolone during pregnancy. Lancet. 1968;1:117–8.

    Article  CAS  PubMed  Google Scholar 

  21. Pirson Y, Van Lierde M, Ghysen J, Squifflet JP, Alexandre GP, van Ypersele de Strihou C. Retardation of fetal growth in patients receiving immunosuppressive therapy. N Engl J Med. 1985;313:328.

    Article  CAS  PubMed  Google Scholar 

  22. Harris JWS, Ross IP. Cortisone therapy in early pregnancy. Relation to cleft palate. Lancet. 1956;267:1045–7.

    Article  Google Scholar 

  23. Kraus AM. Congenital cataract and maternal steroid ingestion. J Pediatr Ophthalmol. 1975;12:1107–8.

    Google Scholar 

  24. Walsh SD, Clark FR. Pregnancy in patients on long-term corticosteroid therapy. Scott Med J. 1967;12:302–6.

    Article  CAS  PubMed  Google Scholar 

  25. Ballard PD, Hearney EF, Smith MB. Comparative teratogenicity of selected glucocorticoids applied ocularly in mice. Teratology. 1977;16:175–80.

    Article  CAS  PubMed  Google Scholar 

  26. Wen SW, Demissie K, Liu S. Adverse outcomes in pregnancies of asthmatic women: results from a Canadian population. Ann Epidemiol. 2001;11:7–12.

    Article  CAS  PubMed  Google Scholar 

  27. Källén B. Maternal drug use and infant cleft lip/palate with special reference to corticoids. Cleft Palate Craniofac J. 2003;40(6):624–8.

    Article  PubMed  Google Scholar 

  28. Edwards MJ, Agho K, Attia J, et al. Case-control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancy. Am J Med Genet A. 2003;120A:459.

    Article  PubMed  Google Scholar 

  29. Chi CC, Mayon-White RT, Wojnarowska FT. Safety of topical corticosteroids in pregnancy: a population-based cohort study. J Invest Dermatol. 2011;131(4):884–91.

    Article  CAS  PubMed  Google Scholar 

  30. Chi C, Wang SH, White RM, Wojnarowska FT. Pregnancy outcomes after maternal exposure to topical corticosteroids. JAMA Dermatol. 2013;149(11):1274–8035.

    Article  PubMed  Google Scholar 

  31. Mahé A, Perret JL, Ly F, Fall F, Rault JP, Dumont A. The cosmetic use of skin-lightening products during pregnancy in Dakar, Senegal: a common and potentially hazardous practice. Trans R Soc Trop Med Hyg. 2007;101(2):183–7.

    Article  PubMed  Google Scholar 

  32. Chi CC, Kirtschig G, Aberer W, Gabbud JP, Lipozencic J, Kárpáti S, et al. Evidence based (S3) guideline on topical corticosteroids in pregnancy. Br J Dermatol. 2011;165(5):943–52. Epub 2011 Sep 29

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Institute of Naval Medicine, INHS Asvini, Colaba, Mumbai, 400005, India

    Manas Chatterjee & Manish Khandare

  2. Department of Obs and Gynae, Command Hospital (Eastern Command), Kolkata, 700027, India

    Vibhu Chatterjee

Authors
  1. Manas Chatterjee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manish Khandare
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vibhu Chatterjee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manas Chatterjee .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Apollo Gleneagles Hospitals and WIZDERM, Kolkata, India

    Koushik Lahiri

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Chatterjee, M., Khandare, M., Chatterjee, V. (2018). Topical Corticosteroid During Pregnancy: Indications, Safety and Precautions. In: Lahiri, K. (eds) A Treatise on Topical Corticosteroids in Dermatology. Springer, Singapore. https://doi.org/10.1007/978-981-10-4609-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-4609-4_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-4608-7

  • Online ISBN: 978-981-10-4609-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation